Klin Farmakol Farm. 2012;26(1):11-13

Comparison of trends in opioid consumption in Slovakia and Czech Republic

Roman Hudec1, Milan Kriška1, Lýdia Božeková1, Viliam Foltán2, Viera Kristová1
1 Ústav farmakológie a klinickej farmakológie LF UK, Bratislava
2 Katedra organizácie a riadenia farmácie FaF UK, Bratislava

Objective: To assess trends in consumption of strong and weak opioid analgesics during the first decade of the 21st century.

Methods: Data were collected from the State Institute for Drug Control in Slovakia. Evaluation was done using the methodology of

defined daily doses per 1000 inhabitants per day. The data obtained were compared with those from the Czech State Institute for Drug

Control and also comparison with statistics from Norway was done.

Resuts: Slovakia has several times higher consumption of strong opioids when compared with the Czech Republic. When evaluating the

consumption of strong opioids in particular, Norway is clearly dominant. Consumption of all the opioids observed is increasing except

a relatively stable consumption of buprenorphine in Slovakia and a decrease in morphine consumption in all the countries.

Conclusions: We hope that these increasing trends will continue. Because we cannot say that there is less pain.

Keywords: consumption, strong opioids, weak opioids, Slovakia, Czech Republic

Published: April 24, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hudec R, Kriška M, Božeková L, Foltán V, Kristová V. Comparison of trends in opioid consumption in Slovakia and Czech Republic. Klin Farmakol Farm. 2012;26(1):11-13.
Download citation

References

  1. Božeková L. Opioidné analgetiká. In: Kriška M. Riziko liekov v medicínskej praxi. SAP, Bratislava, 2000: 354-365.
  2. Hahl M, Ševčík P. Farmakoterapie bolesti. Klin Farmakol Farm 2009; 23(4): 171-173.
  3. Striebel HW. Terapia chronických bolestí. Martin, Osveta 1993: 136.
  4. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003; 63(1): 17-32. Go to original source... Go to PubMed...
  5. Eisenberg E, Adler R. Consumption of opioids in a hospital setting-what can we learn from a 10 year follow-up? Isr Med Assoc J. 2004; 6(1): 19-23. Go to PubMed...
  6. Salvato C, Aretini G, Serraglia D, et al. Opioid prescription for terminal ill outpatients in a district of northern Italy: a retrospective survey. Pharmacol Res. 2003; 48(1): 75-82. Go to original source... Go to PubMed...
  7. Joranson DE, Ryan KM, Gilson AM, et al. Trends in medical use and abuse of opioid analgesics. JAMA. 2000; 283(13): 1710-1714. Go to original source... Go to PubMed...
  8. Tassinari D, Drudi F, Rosati M, et al. Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review. Palliat Med. 2011; 25(5): 478-487. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.